StockNews.com began coverage on shares of Perrigo (NYSE:PRGO – Get Rating) in a research report released on Thursday morning. The firm issued a hold rating on the stock. Shares of Perrigo stock traded down $0.11 on Thursday, reaching $38.32. 1,036,673 shares of the company were exchanged, compared to its average volume of 1,524,471. Perrigo has […]
Perrigo (NYSE:PRGO – Get Rating) updated its FY 2022 earnings guidance on Tuesday. The company provided EPS guidance of $2.100-$2.300 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.670. The company issued revenue guidance of $4.28 billion-$4.33 billion, compared to the consensus revenue estimate of $4.49 billion. Shares of NYSE:PRGO traded […]
Perrigo (NYSE:PRGO – Get Rating) and Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership 89.0% of Perrigo shares are held by […]
State of Alaska Department of Revenue lessened its position in shares of Perrigo Company plc (NYSE:PRGO – Get Rating) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 19,362 shares of the company’s stock after selling 1,165 shares during the period. State of […]
Perrigo Company plc (NYSE:PRGO – Get Rating) EVP Thomas Farrington sold 24,485 shares of the firm’s stock in a transaction on Monday, March 14th. The stock was sold at an average price of $37.13, for a total value of $909,128.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can […]